Tagged Articles

Torrent Pharmaceuticals 3 articles

More heart drugs recalled due to presence of cancer-causing impurity

Two lots of Torrent Pharmaceuticals Limited’s Losartan potassium tablets are the latest heart drugs to be recalled due to the presence of a probable human carcinogen called N-nitrosodiethylamine (NDEA). Losartan is used to treat hypertension, hypertensive patients with left ventricular hypertrophy and for the treatment of nephropathy in type 2 diabetic patients. Patients currently taking Losartan should continue taking the medication because the risk of harm may be greater if the treatment is stopped abruptly without an alternative medication. Patients should contact their pharmacist or physician with concerns. Torrent’s recalled Losartan potassium tablets include Losartan Potassium Tab, USP, 100mg, 30-count ... Read More

Second cancer-causing impurity found in valsartan heart drug

Another suspected cancer-causing impurity has been found in the high blood pressure and heart failure drug valsartan manufactured by Torrent Pharmaceuticals. The Food and Drug Administration (FDA) announced in July that several pills containing the drug ingredient valsartan by various manufacturers were being recalled because they were contaminated with an “unexpected impurity” called N-nitrosodimethylamine, or NDMA. The ingredient is considered a possible carcinogen by the Environmental Protection Agency (EPA). NDMA is an organic chemical byproduct of manufacturing some pesticides and processing fish, and can unintentionally make its way into manufacturing through certain chemical reactions. Not all valsartan-containing drugs are affected ... Read More

More blood pressure pills recalled due to cancer-causing contaminant

The list of valsartan-containing blood pressure and heart failure drugs recalled due to the presence of a cancer-causing substance has once again expanded to include all lots of Torrent Pharmaceuticals Limited valsartan/amlodipine/HCTZ, valsartan/amlodipine, and valsartan tablets, according to the Food and Drug Administration (FDA). The recall was initiated on July 13 for certain valsartan tablets because they were found to contain a chemical known as N-nitrocodimethylamine (NDMA) in levels that exceeded those considered acceptable for public safety. The chemical is sometimes found in water supplies and food and is classified by the Environmental Protection Agency (EPA) as a probable human ... Read More